Fulgent genetics, inc. (FLGT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15
Revenue

7,753

8,387

10,347

8,424

5,370

5,673

5,625

5,400

4,653

4,281

4,503

4,640

5,306

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

5,854

5,011

3,971

3,440

2,901

2,905

Cost of revenue

4,057

3,634

3,885

3,620

2,968

2,769

2,612

2,544

2,772

2,545

2,268

1,879

1,859

1,863

2,143

1,411

1,304

2,726

918

Gross profit

3,696

4,753

6,462

4,804

2,402

2,904

3,013

2,856

1,881

1,736

2,235

2,761

3,447

3,991

2,868

2,560

2,136

175

1,987

Operating expenses:
Research and development

1,978

1,795

1,744

1,574

1,424

1,426

1,438

1,212

1,458

1,324

1,128

920

851

818

1,523

656

561

3,650

311

Selling and marketing

1,597

1,635

1,687

1,304

1,272

1,128

1,115

1,279

1,130

1,080

1,383

851

891

798

893

477

301

1,913

280

General and administrative

2,035

1,732

1,522

1,631

1,529

1,379

1,306

1,366

1,487

1,402

1,205

1,140

1,486

1,116

1,147

457

1,889

1,956

216

Total operating expenses

5,610

5,162

4,953

4,509

4,225

3,933

3,859

3,857

4,075

3,806

3,716

2,911

3,228

2,732

3,563

1,590

2,751

7,519

807

Operating loss

-1,914

-409

1,509

295

-1,823

-1,029

-846

-1,001

-2,194

-2,070

-1,481

-150

219

1,259

-695

970

-615

-7,344

1,180

Interest and other income, net

241

249

189

192

207

98

143

98

95

-

-

-

-

-

-

-

-

-

-

Interest and other income, net

-

-

-

-

-

-

-

-

-

97

145

120

119

57

5

-5,462

13

7

0

Loss before income taxes and equity loss in investee

-1,673

-160

1,698

487

-1,616

-931

-703

-903

-2,099

-1,973

-1,336

-30

338

1,316

-690

-4,492

-

-

-

Income (loss) before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-602

-7,337

1,180

Provision for income taxes

34

-38

61

7

13

888

-318

-100

-434

-596

-415

-110

106

503

417

0

0

-

0

Loss before equity loss in investee

-1,707

-122

1,637

480

-1,629

-1,819

-385

-803

-1,665

-1,377

-921

80

232

813

-1,107

-

-

-

-

Income (loss) before equity in net loss of affiliate

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,492

-

-

-

Equity loss in investee

-249

-174

-175

-149

-279

-234

-210

-246

-245

-247

-172

-105

-

-

-

0

-

-

-

Income (loss) from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

813

-1,107

-4,492

-602

-7,239

1,180

Income (loss) from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-18

59

-896

-821

Net loss

-1,956

-296

1,462

331

-1,908

-2,053

-595

-1,049

-1,910

-1,624

-1,093

-25

232

813

-1,107

-4,510

-543

-7,337

359

Net loss per common share:
Basic

-0.09

-0.01

0.08

0.02

-0.10

-0.11

-0.03

-0.06

-0.11

-

-

-

-

-

-0.46

-0.66

-0.05

-

-

Diluted

-0.09

-0.01

0.08

0.02

-0.10

-0.11

-0.03

-0.06

-0.11

-

-

-

-

-

-0.46

-0.66

-0.05

-

-

Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

Weighted-average common shares:
Basic

21,566

19,762

18,502

18,344

18,228

-

-

-

-

-

-

-

-

-

25,275

12

12,077

-

-

Diluted

21,566

19,762

18,502

18,344

18,228

-

-

-

-

-

-

-

-

-

25,275

12

12,077

-

-

Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0